HuR as Therapeutic Target in Cancer: What the Future Holds
- 1 January 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 29 (1) , 56-65
Abstract
: ELAV-like protein 1 or HuR (human antigen R) is an RNA-binding protein that in humans is encoded by the ELAVL1 gene, and one of its best functions is to stabilize mRNAs in order to regulate gene expression. HuR protein overexpression has undoubtedly been linked to an increased risk of tumor growth, progression and metastasis, rendering it a potential therapeutic target candidate in cancer. Novel agents, interfering with HuR expression, have been tested, both in vitro and in vivo, with promising results. The aim of this paper is to review the existing literature regarding the potential agents that could actively act on and inhibit HuR expression. HuR molecule controls the expression of various proto-oncogenes, cytokines and growth factors, representing a major player in tumor progression, invasion and metastasis and constituting an emerging target for cancer therapy. PubMed database was thoroughly searched, and all published articles providing scientific data on molecules that can exhibit antitumorigenic effects via HuR inhibition were included. According to these data, HuR inhibition should be a promising target in cancer therapeutics.Keywords
This publication has 57 references indexed in Scilit:
- A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex FormationPLOS ONE, 2013
- Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuRMolecular and Cellular Biology, 2012
- Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesisJournal of Clinical Investigation, 2012
- HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endotheliumBritish Journal of Cancer, 2011
- Properties of the Regulatory RNA-Binding Protein HuR and its Role in Controlling miRNA Repression2010
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine KinaseCancer Research, 2009
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivoCancer Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Diverse RNA-Binding Proteins Interact with Functionally Related Sets of RNAs, Suggesting an Extensive Regulatory SystemPLOS Biology, 2008
- Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuRBreast Cancer Research and Treatment, 2007